“…Removing trimethylation of histone 3 lysine 9 via the expression of JmJD2d (Kdm4d) resulted in impaired efficiency of neuronal conversion. The ability of Ascl1 to act as a pioneer transcription factor (Iwafuchi-Doi and Zaret, 2016;Zaret and Mango, 2016) seems to be associated with this epigenetic signature, because in cells with low levels of these marks, such as human keratinocytes and osteoblasts, Ascl1 occupies almost completely different, offtarget sites lacking the E-box motif. These cells, as well as adult human pericytes and human liver cells, can be poorly, if at all, reprogrammed by Ascl1 alone (Karow et al, 2012;Marro et al, 2011;Wapinski et al, 2013).…”